Celldex Therapeutics Inc. (CLDX) Social Stream



Celldex Therapeutics Inc. (CLDX): $37.67

0.08 (-0.21%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add CLDX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#353 of 360

in industry

CELLDEX THERAPEUTICS INC (CLDX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CLDX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-02-14 5 $68 $60 $64.833 $39.68 63.39%
2022-03-01 6 $68 $60 $64.833 $39.68 63.39%
2022-05-06 6 $68 $59 $64.5 $39.68 62.55%
2022-08-09 5 $73 $55 $65.2 $39.68 64.31%
2022-10-10 5 $73 $55 $64.6 $39.68 62.8%
2023-02-27 6 $73 $55 $64.333 $39.68 62.13%
2023-05-05 6 $73 $55 $65 $39.68 63.81%
2023-08-09 6 $73 $54 $63.8 $39.68 60.79%
2023-08-11 6 $73 $54 $64.5 $39.68 62.55%
2023-10-19 7 $73 $21 $58.285 $39.68 46.89%
2023-11-03 7 $73 $21 $59.571 $39.68 50.13%
2023-11-04 7 $73 $21 $59.285 $39.68 49.41%
2023-11-07 7 $80 $21 $63.142 $39.68 59.13%
2023-11-13 8 $80 $27 $63.285 $39.68 59.49%

The Trend in the Analyst Price Target


Over the past 37 weeks, CLDX's average price target has gone down $1.72.

Over the past 43 weeks, CLDX's average upside potential has been 96.51%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-01 6 73 55 65.000 46.43 40%
2023-05-05 6 73 54 64.833 33.28 94.81%
2023-06-12 6 73 54 64.833 37.09 74.8%
2023-08-09 6 73 54 63.800 30.52 109.04%
2023-11-03 7 73 21 59.571 25.98 129.3%

CLDX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 7 0 0 1 1 8

The Trend in the Broker Recommendations


CLDX's average broker recommendation rating worsened by 0.57 over the prior 52 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • CELLDEX THERAPEUTICS INC's variance in analysts' estimates is lower than -735.84% of all US stocks.
  • CELLDEX THERAPEUTICS INC's average analyst price target is greater than 1378.49% of Pharmaceutical Products stocks.
  • CELLDEX THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 1232.54% of stocks in the mid market cap category.
  • In terms of how CELLDEX THERAPEUTICS INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 613.17% of that group.

Stocks similar to CELLDEX THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ZNTL, IGMS, and KRTX.

Is CLDX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!